Therapeutic Advances In Psychopharmacology impact factor, indexing, ranking (2024)


therapeutic

Aim and Scope

The Therapeutic Advances In Psychopharmacology is a research journal published by the Sage Publications. The P-ISSN of this journal is 20451253.

Also, please check the following important details about therapeutic advances in psychopharmacology: Publisher, ISSN, Ranking, Indexing, Impact Factor (if applicable), Publication fee (APC), Review Time, and Acceptance Rate.

According to Clarivate's JCR, journals indexed in SCIE/SSCI have an impact factor.


Important Metrics

Journal Title: Therapeutic Advances in Psychopharmacology
Publisher: Sage Publications
P-ISSN: 20451253
Open Access:
Status: Inactive
Scopus Coverage: 2011-2015

Indexing

The therapeutic advances in psychopharmacology is indexed in:

An indexed journal means that the journal has gone through and passed a review process of certain requirements done by a journal indexer.

The Web of Science Core Collection includes the Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts & Humanities Citation Index (AHCI), and Emerging Sources Citation Index (ESCI).


Therapeutic Advances In Psychopharmacology Impact Factor 2024

The latest impact factor of therapeutic advances in psychopharmacology is 3.4 which is recently updated in June, 2024.

The impact factor (IF) is a measure of the frequency with which the average article in a journal has been cited in a particular year. It is used to measure the importance or rank of a journal by calculating the times it's articles are cited.

Note: Every year, The Clarivate releases the Journal Citation Report (JCR). The JCR provides information about academic journals including impact factor. The latest JCR was released in June, 2023. The JCR 2024 will be released in the June 2024.


Publication fee

According to journal website, the publication fee of therapeutic advances in psychopharmacology is around 2300 USD.

The therapeutic advances in psychopharmacology has also Journal waiver policy (for developing countries, authors etc).

An article processing charge (APC), also known as a publication fee, is a fee which is sometimes charged to authors. Most commonly, it is involved in making a work available as open access (OA), in either a full OA journal or in a hybrid journal.


Journal Publication Time

The Journal Publication Time means the average number of weeks between article submission and publication. According to the journal website, the therapeutic advances in psychopharmacology publishes research articles in 10 weeks on an average.



Call for Papers

Visit to the official website of the journal/ conference to check the details about call for papers.

How to publish in Therapeutic Advances In Psychopharmacology?

If your research is related to the scope of the journal, then visit the official website of therapeutic advances in psychopharmacology and send your manuscript.

Tips for publishing in Therapeutic Advances In Psychopharmacology:

Acceptance Rate

Acceptance rate is the ratio of the number of articles submitted to the number of articles published. Researchers can check the acceptance rate on the journal website. Alternatively, they can contact the editor of the journal.

Final Summary

  • The impact factor of therapeutic advances in psychopharmacology is 3.4.
  • The therapeutic advances in psychopharmacology is a reputed research journal.
  • It is published by Sage Publications.
  • The journal is indexed in UGC CARE, SCIE, DOAJ, PubMed.
  • It is an open access journal.
  • The publication time (Average number of weeks between article submission and publication) of the journal is 10 weeks.
  • The Publication fee (APC) of therapeutic advances in psychopharmacology 2300 USD.

Sources: https://journals.sagepub.com/home/tpp







TOP RESEARCH JOURNALS

Credit and Source: Scopus, Clarivate, UGC CARE.